Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Telix Pharmaceuticals
ISIN AU000000TLX2
|WKN A2H7JK
Market cap (in EUR)
2,147 m
Country
Australia
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.
Healthcare Healthcare Equipment Other Medical Devices Australia
Financials
Key metrics
| Market capitalisation, EUR | 2,147 m |
| EPS, EUR | - |
| P/B ratio | 5.8 |
| P/E ratio | 221.1 |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 478 m |
| Net income, EUR | 30 m |
| Profit margin | 6.37% |
What ETF is Telix Pharmaceuticals in?
There are 23 ETFs which contain Telix Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of Telix Pharmaceuticals is the Xtrackers S&P/ASX 200 UCITS ETF 1D.
Savings plan offers
Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
Source: justETF Research; As of 1/2026; *Affiliate link
- The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
- No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
- The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
- No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.